Sterling Accuris Diagnostics, founded in 2015 by Gujarat industrialist Mr. Girish Patel, has become one of the fastest‑growing NABL‑accredited pathology chains with a strong presence in Gujarat, Rajasthan, Madhya Pradesh, and Delhi. The Ahmedabad network includes 8+ laboratories and 20+ collection centres acquired from Gujarat Pathology Laboratory (est. 1998), enabling comprehensive B2C, B2B, hospital, and corporate services.
The chain offers 2,000+ tests across molecular diagnostics, histopathology, cytology, immunohistochemistry, autoimmune, immunoassays, microbiology, clinical chemistry, haematology, coagulation, and infectious diseases, using bi‑directionally interfaced state‑of‑the‑art equipment for minimal manual intervention and quick TAT.
Key services & features
-
-
Routine: blood tests, thyroid, diabetes, lipid, liver/kidney panels, vitamins.
-
Advanced: molecular (PCR), histopathology, cytology, immunohistochemistry, autoimmune disorders, specialized microbiology.
-
-
-
250+ collection centres/labs; free home blood sample collection; full body health checkups; fast, accurate digital results.
-
-
-
Bi‑directional lab equipment interfacing; NABL accreditation; ICMR‑approved COVID testing capabilities.
-
Achievements & highlights
-
Fourth acquisition in two years (Gujarat Pathology Lab in 2025), strengthening Ahmedabad dominance with 8 labs + 20 centres.
-
Backed by Morgan Stanley Private Equity Asia; positioned as emerging diagnostics leader through quality, efficiency, and rapid expansion.
